ERIC F SEVERSON PA-C
Prescription History 1790776599
Pain Medicine - Interventional Pain Medicine in Wasilla, AK

NPI Status: Active since October 31, 2005

Contact Information

3066 E MERIDIAN PARK LOOP STE 207
WASILLA, AK
ZIP 99654
Phone: (907) 357-7710
Fax: (907) 357-7720

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ERIC F SEVERSON PA-C, an active Interventional Pain Medicine specialist practicing in Wasilla, AK. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 119 documented patient claims. Among these therapy options, the most frequently utilized medication is Hydrocodone-Acetaminophen, which accounts for 36 claims alone.

Medication Index


Gabapentin

Generic Formulation: GabapentinSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 13
30-Day Fills 27.0
Days Supply 810
AK State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills78.3
Peer Average Days Supply2,155
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.0% less volume than the regional standard for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $263.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.28

State Avg Cost Per Claim

$22.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 36
30-Day Fills 36.0
Days Supply 997
AK State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills44.7
Peer Average Days Supply886
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $493.09 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.70

State Avg Cost Per Claim

$21.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Oxycodone-Acetaminophen

Generic Formulation: Oxycodone Hcl/AcetaminophenSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 565
AK State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills40.0
Peer Average Days Supply876
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.3% less volume than the regional standard for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $438.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.06

State Avg Cost Per Claim

$27.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Pregabalin

Generic Formulation: PregabalinSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 22
30-Day Fills 42.2
Days Supply 1,263
AK State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills39.7
Peer Average Days Supply1,121
Conservative Utilization

This provider writes prescriptions for this formulation 26.7% less frequently than the standard regional baseline metric for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,003.12 across this reporting matrix range.

Provider Avg Cost Per Claim

$45.60

State Avg Cost Per Claim

$49.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 29
30-Day Fills 36.0
Days Supply 1,060
AK State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills38.0
Peer Average Days Supply991
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $611.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.08

State Avg Cost Per Claim

$16.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like ERIC F SEVERSON PA-C provides transparency into local medical care patterns within Wasilla, AK.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Interventional Pain Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.